The 3rd edition of Biotech France 2019 International Conference and Exhibition

Biotech France 2019
26 Jun - 28 Jun 2019 | Paris - France
Conference Speakers
Keynote Speakers
1549227677_ProfDonaldMartin.jpg
Grenoble University, France

Prof. Martin received a bachelors degree in optometry, a masters degree in biomedical engineering and a PhD in biomechanics of contact lenses/biophysics of the anterior eye from the University of New South Wales (Australia). He was awarded the inaugural Medical Foundation Post-Doctoral Fellowship (3 years) to complete postdoctoral training in electrophysiology at the University of Sydney. He then continued the first part of his career in Australia, until 2008, with...

More

Prof. Martin received a bachelors degree in optometry, a masters degree in biomedical engineering and a PhD in biomechanics of contact lenses/biophysics of the anterior eye from the University of New South Wales (Australia). He was awarded the inaugural Medical Foundation Post-Doctoral Fellowship (3 years) to complete postdoctoral training in electrophysiology at the University of Sydney. He then continued the first part of his career in Australia, until 2008, with scientific and academic positions at St Vincent’s Hospital Sydney and the University of Technology Sydney. From 2003-2008 he was an executive board member of the Australian French Association for Science and Technology (AFAS NSW). In 2005 he initiated the Australian network in nanobiotechnology called OzNano2Life, which directly funded postdoctoral researchers in several universities and institutions across Australia and provided the portal for exchanging structured scientific information with nanotechnology institutes in Europe. In 2009 he was awarded a French Chaire d’Excellence to establish a research program in nanobiosciences at the Fondation Nanosciences and the Université Grenoble Alpes. In 2013 he was appointed to the continuing position of Professeur des Universités, Université Grenoble Alpes. He also has an honorary position at the University of Melbourne (Australia). He is the co-author on 11 patents, more than 100 publications and is co-founder in 3 Australian startups. His book on nanobiotechnology published by Springer in 2007 was translated to Russian and published in 2012 by Nauchny Mir, Moscow

Less
1549227992_ProfMarkSmales.jpg
University of Kent, United Kingdom

Professor Mark Smales is Professor of Industrial Biotechnology in the School of Biosciences at the University of Kent. The group headed by Mark has a number of on-going projects whose objectives are to further advance our understanding of biotechnological products and processes at the fundamental biological or chemical level to enable their manipulation and control for improved (a) biotherapeutic recombinant protein yields and quality, (b) manufacture of gene therapies,...

More

Professor Mark Smales is Professor of Industrial Biotechnology in the School of Biosciences at the University of Kent. The group headed by Mark has a number of on-going projects whose objectives are to further advance our understanding of biotechnological products and processes at the fundamental biological or chemical level to enable their manipulation and control for improved (a) biotherapeutic recombinant protein yields and quality, (b) manufacture of gene therapies, (c) re-tuning of cell metabolism via synthetic biology approaches. His group in particular focusses upon the investigation of cultured mammalian cells for the purposes of producing biotherapeutic proteins for the treatment of disease, for the generation of diagnostics and for manufacturing of gene therapies. This includes upstream and downstream bioprocessing and embracing and utilising novel technologies such as genome editing to engineering cell systems and tune them for the desired use. A further aspect of his work is around mRNA translation and its control. He has a particular interest in how both initiation and elongation message specific control is achieved by the cell when under specific stresses, particularly in response to cold-shock.


Mark is Director of the Industrial Biotechnology Centre and a member of the Industrial Biotechnology and Synthetic Biology Research Group.

Less
1549228429_DrMargitWinkler.jpg
Graz University of Technology, Austria

Dr. Margit Winkler is Elise-Richter fellow at Graz University of Technology and Senior Researcher at the Austrian Center of Industrial Biotechnology. She studied technical chemistry and completed her PhD in Organic Chemistry. As Erwin-Schrödinger fellow, she joined David O’Hagan at the University of St. Andrews. Margit obtained her venia docendi in Biotechnology in 2019. Her research focus is on biocatalysis and she is interested to find and to improve enzymes...

More

Dr. Margit Winkler is Elise-Richter fellow at Graz University of Technology and Senior Researcher at the Austrian Center of Industrial Biotechnology. She studied technical chemistry and completed her PhD in Organic Chemistry. As Erwin-Schrödinger fellow, she joined David O’Hagan at the University of St. Andrews. Margit obtained her venia docendi in Biotechnology in 2019. Her research focus is on biocatalysis and she is interested to find and to improve enzymes for challenging chemical transformation and to use them in a biotechnological context.

Less